Alumni Ventures Group

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.

Andrew Baum

Vice President, Treasury and Capital Management

David Beazley

Managing Partner

Matthew Caspari

Managing Partner

Matt Castellini

Senior Associate

Helen Chen

CEO Services Analyst

Past deals in Health Care

Helper Bees

Series C in 2025
Founded in 2015, Helper Bees operates a platform connecting seniors with local helpers for various home care services in the United States. It partners with insurance carriers to enhance home care experiences through digitization, intelligent care sourcing, and machine learning-driven analytics.

MetaSight Diagnostics

Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).

Bionic Health

Seed Round in 2024
Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.

Syntra

Pre Seed Round in 2024
Syntra develops an EHR platform that streamlines billing, records, and follow-ups, helping doctors automate tasks.

InGel Therapeutics

Seed Round in 2024
InGel Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing engineered cell therapies aimed at targeting neuroprotective pathways to address retinal degeneration. Utilizing stem cells and their secretome, InGel Therapeutics aims to provide neuroprotection for blinding diseases such as retinitis pigmentosa and macular degeneration. The company leverages biodegradable polymers to isolate neuroprotective proteins, initially testing these solutions in vitro before advancing to in vivo applications. Through its innovative approach, InGel Therapeutics seeks to enable healthcare professionals to more effectively treat patients suffering from retinal degeneration.

Grayce

Series A in 2024
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.

caVos biotherapeutics

Seed Round in 2024
An emerging genomic and data science company, developing novel drugs based on naturally occurring resistance mechanisms

Bionaut Labs

Series B in 2024
Founded in 2016, Bionaut Labs specializes in developing intra-tissue navigation platforms using micro-robots for precise anatomical targeting. Its innovative technology enables remote-controlled delivery of therapeutics to challenging clinical settings, revolutionizing the treatment of central nervous system disorders and other diseases.

HelixNano

Series A in 2024
HelixNano is a biotechnology startup that employs artificial intelligence and synthetic biology to develop innovative treatments for genetic diseases. Founded with backing from Y Combinator and venture capitalists, the company initially focused on creating cancer vaccines over two years. Currently, HelixNano is adapting its technology to combat COVID-19, aiming to produce precise and safe vaccine candidates. Its long-term goal is to develop a universal coronavirus vaccine that protects against future outbreaks.

Nest Health

Seed Round in 2024
Nest Health is a family healthcare platform that brings medical services to the home through in-home and virtual visits. It serves patients across newborns, children, teens, and adults with a wide range of services including medical, behavioral health, and nutrition support, as well as preventive care, sick visits, and chronic disease management. The company aims to reduce the burden of arranging care by enabling patients to receive necessary treatments and consultations without leaving home, delivering convenient and accessible care in the familiar setting of the home.

Oula Health

Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

BetterYou

Series A in 2023
BetterYou is a digital wellness platform that uses data from users' devices to help individuals align daily time with personal values and wellness goals. It reveals how time is spent and what matters, guiding users to focus on activities across physical, mental, social, and educational wellness. The platform also provides organizations with population-level insights to improve employee wellness and support health savings.

Mending

Seed Round in 2023
Mending develops a health insurance platform that aims to provide affordable, comprehensive care by strengthening the relationship between patients and primary care providers. The platform supports primary care and mental health visits, features low deductibles, and connects users to a broad network of doctors and hospitals, helping individuals and small businesses receive timely, personalized healthcare at a low cost.

MedScout

Seed Round in 2023
MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers a sales enablement software that integrates medical claims intelligence from both public and private payors, providing a user-friendly interface specifically designed for sales professionals and leaders. The platform delivers immediate insights into the addressable market within existing territories and facilitates understanding of market dynamics. By supplying comprehensive information on patient demographics, procedure volumes, referral patterns, and payment data, MedScout empowers its clients to optimize their sales strategies and enhance operational productivity, ultimately driving growth in the life sciences sector.

Bionic Health

Seed Round in 2023
Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.

Oula Health

Series A in 2023
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Koala Health

Series A in 2022
Founded in 2021, Koala Health simplifies pet care by providing medications and health products through its digital platform. It offers features such as prescription management, date-and-time-based packaging, and free delivery.

Nanopath

Series A in 2022
Nanopath is a molecular diagnostics company that develops innovative platforms for rapid disease diagnosis. Its technology enables point-of-care testing, eliminating the need for nucleic acid amplification and supporting multiplexed detection. This allows patients and healthcare providers to access accurate diagnostic results within standard office visits, improving healthcare outcomes.

Swing Therapeutics

Series A in 2022
Swing develops safe and effective digital therapeutics for chronic conditions, partnering with top researchers to create evidence-based treatments. Their solutions empower patients to manage their illnesses, improving health outcomes.

Boulder Care

Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Satellite Bio

Series A in 2022
Satellite Bio develops cell therapies and regenerative medicine approaches, spanning cell biology, tissue engineering, and synthetic biology. The company focuses on proprietary, off-the-shelf implantable satellite organs that function as living therapeutic systems to replace or augment critical organ functions in patients with serious diseases, enabling medical professionals to address conditions arising from genetic and environmental factors. Its platform supports the development of modular, scalable therapies aimed at treating complex diseases and transforming patient outcomes.

Heading Health

Seed Round in 2022
Heading Health is a technology-driven platform enhancing access to affordable mental health care. It offers personalized treatment solutions, combining evidence-based therapeutics with advanced technologies like transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine.

Helper Bees

Series B in 2022
Founded in 2015, Helper Bees operates a platform connecting seniors with local helpers for various home care services in the United States. It partners with insurance carriers to enhance home care experiences through digitization, intelligent care sourcing, and machine learning-driven analytics.

Insiteflow

Seed Round in 2021
Insiteflow provides an EHR integrated platform that supports clinical decision solutions and optimizes clinical workflows. The platform delivers point-of-care insights to improve decision making and treatment planning. It deploys automated EHR workflows to boost user adoption, efficiency and effectiveness, and features patent-pending technology. The system writes clinicians' and staff decisions into EHR databases to enable improvements at key decision points in care. Founded in 2018 in Austin, Texas by Anthony Gerardi and Corey Hall.

Gordy Health

Convertible Note in 2021
Gordy Health is a virtual care provider based in Pasadena, California, founded in 2021. The company specializes in blood pressure management to reduce patients' risk of heart attack, stroke, and kidney failure. Gordy Health offers a healthcare platform that allows users to manage their blood pressure from home, with features including direct access to heart specialists, easy-to-schedule virtual appointments, real-time diagnostics, prescription delivery, and ongoing monitoring and medication adjustments. The goal is to prevent complications from high blood pressure, helping patients achieve healthier lives and increased longevity.

Evernow

Convertible Note in 2021
Evernow offers comprehensive women's healthcare services focused on menopause. Their platform provides online access to specialized doctors, evidence-based information, treatments, and supportive communities, empowering women to manage hormonal changes and improve their overall health.

BetterYou

Venture Round in 2021
BetterYou is a digital wellness platform that uses data from users' devices to help individuals align daily time with personal values and wellness goals. It reveals how time is spent and what matters, guiding users to focus on activities across physical, mental, social, and educational wellness. The platform also provides organizations with population-level insights to improve employee wellness and support health savings.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Veralox Therapeutics

Series A in 2021
Veralox Therapeutics specializes in the development of small molecule therapeutics aimed at addressing the underlying pathologies of thrombosis and type one diabetes. The company focuses on innovative treatment paradigms informed by a deep understanding of the molecular mechanisms involved in these diseases. By targeting conditions such as heparin-induced thrombocytopenia and thrombosis, Veralox Therapeutics aims to enhance patient outcomes and facilitate complete recovery from diabetes. Through its research and development efforts, the company seeks to provide effective and transformative therapies for individuals affected by these serious health conditions.

Insiteflow

Seed Round in 2021
Insiteflow provides an EHR integrated platform that supports clinical decision solutions and optimizes clinical workflows. The platform delivers point-of-care insights to improve decision making and treatment planning. It deploys automated EHR workflows to boost user adoption, efficiency and effectiveness, and features patent-pending technology. The system writes clinicians' and staff decisions into EHR databases to enable improvements at key decision points in care. Founded in 2018 in Austin, Texas by Anthony Gerardi and Corey Hall.

Intus Care

Seed Round in 2021
Founded in 2018, Intus Care develops a platform that connects home care providers with patients. Its application uses machine learning to predict hospital readmissions and risks, enabling efficient tracking of care providers and high-risk patient identification.

Bend

Series A in 2021
Bend Financial, Inc. specializes in designing and developing health savings account management solutions. Founded in 2017 and headquartered in Boston, Massachusetts, the company offers a suite of services aimed at enhancing health plan management. As a next-generation provider of health savings accounts, Bend Financial focuses on delivering innovative tools that facilitate better management of health-related expenses for individuals and organizations.

KLOWEN Braces

Seed Round in 2021
KLOWEN Braces, Inc. specializes in the development of custom braces systems designed for orthodontists and their patients. Established in 2019 and headquartered in Fort Collins, Colorado, the company utilizes an innovative software platform to ensure the precise placement of uniquely shaped brackets for each tooth. KLOWEN Braces offers a range of orthodontic components, including modular brackets, hooks, bundles, tubes, and wires, all available through online channels. Its systems aim to provide a faster, more effective, and more comfortable alternative to traditional braces, enhancing the overall orthodontic treatment experience.

Unlearn.AI

Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Grayce

Seed Round in 2020
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.

Unlearn.AI

Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Clarent

Seed Round in 2020
Clarent is a developer of compliance software tailored for senior living providers, offering a platform that consolidates data from diverse sources, including electronic health records, financial systems, and resident care records. This integration enables senior living teams to create a unified source of truth, facilitating the calculation of over 150 industry-specific key performance indicators. By organizing data into accessible reports and dashboards, Clarent empowers owners and operators to track trends, identify areas for improvement, and make informed, data-driven decisions regarding their operations and resident care.

Gallant Pet

Venture Round in 2020
Gallant Pet, Inc. is a pet service company based in San Diego, California, that specializes in stem cell preservation services for pets. Founded in 2018 by Aaron Hirschhorn, the company collects and banks stem cells from tissue during routine spay or neuter procedures. Gallant Pet also provides a platelet-rich plasma (PRP) kit for treatment of dogs suffering from osteoarthritis or other musculoskeletal conditions. In addition to its preservation services, Gallant Pet is involved in clinical research to develop effective stem cell therapies for pets. The company's focus on retrieving and preserving regenerative cells allows pet owners to utilize their pets' young stem cells for potential treatments when needed.

Matchwell

Venture Round in 2020
Matchwell LLC, established in 2017 and headquartered in Durham, North Carolina, operates an online marketplace that connects clinicians with healthcare facilities. The platform allows clinicians to join facility pools of their choice, view available shift information, and communicate directly with hiring managers. With over 50,000 registered clinicians and more than 1,000 contracted sites of care, Matchwell facilitates efficient workforce management by leveraging AI for transparency and flexibility in healthcare staffing arrangements.

Emme

Seed Round in 2019
Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on improving women's health, particularly in the area of birth control. The company has developed an integrated smart case device and mobile application designed to help women take their birth control pills consistently. This multi-sensor technology tracks pill consumption, alleviates the need for users to remember to take their medication, and alerts those at risk of unintended pregnancy when back-up contraception is necessary. Additionally, the accompanying app provides users with a comprehensive overview of their health by enabling tracking of menstrual cycles, moods, and side effects. Emme aims to modernize the birth control experience, making it more user-friendly and aligned with the demands of contemporary life.

She's Well

Seed Round in 2019
She's Well provides fertility management services through a subscription model and financing plans, enabling individuals and couples to access fertility testing, IVF, egg freezing, and sperm freezing via a network of leading fertility centers. The company combines financial options with on-demand concierge care to simplify the fertility journey, offering guidance and support to make fertility care more affordable and accessible for people who want to start a family on their own timeline.

Tempest

Series A in 2019
Tempest, Inc. is a digital recovery program that provides online courses and resources for individuals seeking to quit alcohol. Founded in 2014 and based in New York, the company offers a comprehensive virtual curriculum that includes an eight-week course, counseling sessions, and workshops designed to address the challenges of alcohol addiction. Tempest emphasizes the development of purpose, meaning, and creativity as essential components of a sober lifestyle. The program aims to support participants in overcoming negativity and mental health challenges associated with substance use, ultimately helping them lead healthier and more fulfilling lives. Originally established as Hip Sobriety, Inc., the company rebranded to Tempest, Inc. in May 2019.

HENRY The Dentist

Series A in 2019
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Careswitch

Venture Round in 2019
Careswitch streamlines home care operations through its software platform. It automates tasks such as care planning, scheduling, documentation, payroll, billing, and invoicing. The platform also facilitates caregiver-family communication and ensures compliance.

Tempest

Venture Round in 2019
Tempest, Inc. is a digital recovery program that provides online courses and resources for individuals seeking to quit alcohol. Founded in 2014 and based in New York, the company offers a comprehensive virtual curriculum that includes an eight-week course, counseling sessions, and workshops designed to address the challenges of alcohol addiction. Tempest emphasizes the development of purpose, meaning, and creativity as essential components of a sober lifestyle. The program aims to support participants in overcoming negativity and mental health challenges associated with substance use, ultimately helping them lead healthier and more fulfilling lives. Originally established as Hip Sobriety, Inc., the company rebranded to Tempest, Inc. in May 2019.

Careswitch

Seed Round in 2019
Careswitch streamlines home care operations through its software platform. It automates tasks such as care planning, scheduling, documentation, payroll, billing, and invoicing. The platform also facilitates caregiver-family communication and ensures compliance.

HENRY The Dentist

Series A in 2019
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Somna Therapeutics

Venture Round in 2018
Somna Therapeutics LLC, founded in March 2012 in partnership with the Medical College of Wisconsin, is a medical device company based in Germantown, Wisconsin. The company specializes in developing solutions for laryngopharyngeal reflux (LPR) and extraesophageal acid reflux diseases (EERD). Its primary product, the Reza Band, is a non-pharmacologic, investigational device designed to prevent reflux into the larynx, pharynx, and lungs. This non-invasive device aims to improve the quality of life for individuals suffering from these conditions. Somna Therapeutics is currently focused on optimizing product design and completing clinical trials to obtain FDA clearance, with plans to market the Reza Band to hospitals, physician clinics, and home health care providers upon successful approval and launch.

Apprentice Health

Seed Round in 2018
Apprentice Health optimizes clinical workflows using real-time location systems, ambient sensors, and AI. Its platform enhances patient scheduling, room utilization, and equipment tracking, reducing wait times and improving operational efficiency for healthcare providers.

Eva

Venture Round in 2018
Higia Technologies, founded in 2016 and based in Mexico City, specializes in developing EVA, a non-invasive wearable device aimed at assessing breast cancer risk. This innovative device features tactile sensors that map the surface of the breast and its surrounding areas. By continuously monitoring changes in breast temperature, size, and weight through embedded biosensors, EVA empowers women to actively track their breast health. The company's focus is on making breast cancer risk assessment more accessible and user-friendly.

Honor

Series C in 2018
Honor operates a large in-home senior care network and technology platform that connects older adults with professional caregivers and home care agencies to deliver high-quality, personalized care in the comfort of their homes. The company combines scalable workforce management and technology with a network of care providers to coordinate reliable, transparent services that support aging in place. Through strategic expansion, including the 2021 acquisition of Home Instead, Honor leverages its platform and global network to improve quality of life for seniors and support families and care professionals.

Heal

Series C in 2018
Heal is a healthcare provider focused on delivering value-based, in-home primary care primarily to seniors on Medicare and select Medicare Advantage plans. The company emphasizes the importance of patient comfort by offering services in the familiar environment of patients' homes. Board-certified doctors and nurse practitioners at Heal dedicate ample time to each patient, fostering strong relationships and ensuring thorough, unrushed care. Heal addresses a wide range of healthcare needs, from preventive services like flu shots and annual physicals to the management of chronic conditions and treatment of common illnesses. Additionally, the company provides telemedicine options and remote health monitoring, facilitating easy access to care when needed. Patients can schedule appointments conveniently through phone support, with availability seven days a week, including weekends and holidays.

Emme

Seed Round in 2018
Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on improving women's health, particularly in the area of birth control. The company has developed an integrated smart case device and mobile application designed to help women take their birth control pills consistently. This multi-sensor technology tracks pill consumption, alleviates the need for users to remember to take their medication, and alerts those at risk of unintended pregnancy when back-up contraception is necessary. Additionally, the accompanying app provides users with a comprehensive overview of their health by enabling tracking of menstrual cycles, moods, and side effects. Emme aims to modernize the birth control experience, making it more user-friendly and aligned with the demands of contemporary life.

DOTS

Venture Round in 2018
DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.

Center Health

Seed Round in 2018
Center Health develops an AI-powered assistant and connected blood sugar meter for managing diabetes. It provides personalized insights through simple logging and collaboration, aiming to help users regain control of their lives.

HENRY The Dentist

Seed Round in 2017
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Respiratory Motion

Venture Round in 2017
Respiratory Motion, Inc. is a medical device company headquartered in Waltham, Massachusetts, that specializes in respiratory monitoring systems. Established in 2011, the company focuses on the development and commercialization of innovative devices designed to monitor respiratory variation and vital respiratory parameters. Its flagship product, ExSpiron, is a point-of-care device that non-invasively measures minute ventilation, tidal volume, and respiratory rate, providing physicians with critical data to enhance patient safety and outcomes. Respiratory Motion's technology enables continuous monitoring across diverse patient populations and clinical environments, offering early warnings of potential respiratory collapse. The company's systems have received FDA clearance, underscoring their commitment to advancing respiratory health care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.